Emerging roles of vitamin D: More reasons to address widespread vitamin D insufficiency

Molecular Aspects of Medicine

Volumn 29, Issue 6, 2008, Pages 359-360

  Harris, Susan ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

AUTOCRINE EFFECT; BONE METABOLISM; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; DIETARY INTAKE; EDITORIAL; ENDOCRINE FUNCTION; NUTRITIONAL ASSESSMENT; PARACRINE SIGNALING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANIMALS; DIET; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 56149125422     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2008.08.010     Document Type: Editorial

References (18)

1. Aloia J.F., Patel M., Dimaano R., Li-Ng M., Talwar S.A., Mikhail M., Pollack S., and Yeh J.K. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am. J. Clin. Nutr. 87 (2008) 1952-1958
2. Anderson P.H., and Atkins G.J. The skeleton as an intracrine organ for vitamin D metabolism. Mol. Aspects Med. 29 (2008) 397-406
3. Baeke F., van Etten E., Gysemans C., Overbergh L., and Mathieu C. Vitamin D signaling in immune-mediated disorders evolving insights and therapeutic opportunities. Mol. Aspects Med. 29 (2008) 376-387
4. Bischoff-Ferrari H.A. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv. Exp. Med. Biol. 624 (2008) 55-71
5. Brown A.J., and Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol. Aspects Med. 29 (2008) 433-452
6. Buell J.S., and Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing decline?. Mol. Aspects Med. 29 (2008) 415-422
7. Cantorna M. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Aspects Med. 29 (2008) 369-375
8. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 29 (2008) 407-414
9. Dawson-Hughes B. Vitamin D and calcium: recommended intake for bone health[Review] [35 refs]. Osteoporos Int. 8 Suppl 2 (1998) S30-S34
10. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 16 (2005) 713-716
11. Fleet, J.C. 2008. Molecular actions of vitamin D contributing to cancer prevention. Mol. Aspects Med. 29, 388-396.
12. Hathcock J.N., Shao A., Vieth R., and Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 85 (2007) 6-18
13. Holick M.F. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol. Aspects Med. 29 (2008) 361-368
14. Kimlin M.G. Geographic location and vitamin D synthesis. Mol. Aspects Med. 29 (2008) 453-461
15. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., and Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 (2002) 771-777
16. Melamed M.L., Michos E.D., Post W., and Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Int. Med. 168 (2008) 1629-1637
17. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNBIoM, 1997. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press.
18. Zittermann A., and Koerfer R. Protective and toxic effects of vitamin D on vascular calcification. Mol. Aspects Med. 29 (2008) 423-432